On August 26, Dycom fell 5.06% in pre-market trading, trading at approximately $336.97/share, with turnover of $11.47 million. Despite record fiscal Q2 results that significantly exceeded Wall Street expectations, the stock sold off as the company's full-year guidance raise was seen as underwhelming.

Dycom reported fiscal Q2 adjusted EPS of $5.29, beating the analyst consensus estimate of $4.72 by 12.08% and representing a 58.86% year-over-year increase. Contract revenue came in at $2.01 billion versus $1.98 billion expected. However, the company only lifted its fiscal 2027 full-year contract revenue guidance to $7.48 billion–$7.66 billion, a marginal increase from the prior range of $7.38 billion–$7.65 billion. This contrasts sharply with the first quarter, when Dycom raised its full-year outlook from $6.85 billion–$7.15 billion to $7.38 billion–$7.65 billion, a move that drove the stock up over 28% in a single session. The limited scope of the current revision appears to have disappointed investors who had anticipated a similarly aggressive upward adjustment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)